Skip to content

Exagen Inc. XGN Purchase obligation, 2025

Purchase obligation, 2025 at other companies

Rumble, Inc. logo
Rumble, Inc.RUM
$46M-8.0%
Evommune
 logo
Evommune EVMN
$725K
CorMedix logo
CorMedixCRMD
$30M
Citizens Financial Services, Inc. logo
Citizens Financial Services, Inc.CZFS
$515.58M+16.7%
AZZ logo
AZZAZZ
$1.4M-82.9%
Employers Holdings logo
Employers HoldingsEIG
$7.7M-44.2%

Other financials

Income statement

See full
Revenue$17.3M+11.7%
Gross profit$10.2M+11.9%
Operating income-$3.4M-1.5%
Net income-$4.0M-5.7%
EPS (diluted)-$0.17+15.0%

Balance sheet

See full
Cash & equivalents$21.7M+90.6%
Total debt$27.1M+15.8%
Total equity$14.4M+125%
Total assets$52.0M+28.9%

Cash flow

See full
Operating cash flow-$10.4M+2.4%
CapEx$228.0K+102%
Free cash flow-$10.6M+1.3%

Valuation

See full
Market cap$112.34M-26.5%
Enterprise value$117.78M-20.3%
P/S1.6×-1.0×

Profitability

See full
Gross margin58.3%-1.0pp
Operating margin-20.6%-2.9pp
Net margin-29.5%+2.5pp
FCF margin-27.5%

Returns & leverage

See full
Return on equity-193.6%+355pp
Debt / equity1.9×-1.8×
Current ratio3.5×+1.1×

Where this comes from

Reported directly by Exagen Inc. in its filing.

Tagged under the XBRL concept exdx:PurchaseObligationPaidInCurrentFiscalYear.

The official record: Exagen Inc.’s 10-K, filed March 10, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s purchase obligation, 2025.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exagen Inc.'s purchase obligation, 2025?
Exagen Inc. (XGN) reported purchase obligation, 2025 of $3M in Q4 2025.
What does purchase obligation, 2025 mean?
The portion of total purchase obligations that is scheduled for payment within the current fiscal year. This metric provides visibility into near-term cash requirements related to supply chain and operational contracts. It is vital for short-term liquidity planning and assessing the company's immediate cash obligations.